Safinamide and flecainide protect axons and reduce microglial activation in models of multiple sclerosis. (Q46490485)

From Wikidata
Jump to navigation Jump to search
scientific article published on 20 March 2013
edit
Language Label Description Also known as
English
Safinamide and flecainide protect axons and reduce microglial activation in models of multiple sclerosis.
scientific article published on 20 March 2013

    Statements

    Safinamide and flecainide protect axons and reduce microglial activation in models of multiple sclerosis (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit